ID

26231

Descripción

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Third party follow-up - Repeating form (Scheduled/Dynamic visit)

Palabras clave

Versiones (3)
  1. 12/10/17 12/10/17 -
  2. 23/10/17 23/10/17 -
  3. 2/1/18 2/1/18 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

12 de octubre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Third party follow-up GSK study Chronic Coronary Heart Disease NCT00799903

Inglés

Third party follow-up GSK study Chronic Coronary Heart Disease NCT00799903

1 formularios  
Date of last contact attempt
Descripción

Date of last contact attempt

1. Date of most recent attempt to contact third party
Descripción

Date of last contact attempt

Tipo de datos

date

Contact details
Descripción

Contact details

2. Was contact successful? (i.e. actually spoke to someone)
Descripción

contact successful

Tipo de datos

boolean

If contact successful: Type of third party contact
Descripción

Type of third party contact

Tipo de datos

text

Other type of third party contact
Descripción

Other type of third party contact

Tipo de datos

text

Are there any new study endpoints to report?
Descripción

If Yes, complete SAE-EP and appropriate Endpoint forms.

Tipo de datos

text

Date endpoint information assessed by third party
Descripción

Date endpoint information assessed by third party

Tipo de datos

date

Volver a la parte superior de la página

Similar models

Third party follow-up GSK study Chronic Coronary Heart Disease NCT00799903

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Date of last contact attempt
Date of last contact attempt
Item
1. Date of most recent attempt to contact third party
date
Item Group
Contact details
contact successful
Item
2. Was contact successful? (i.e. actually spoke to someone)
boolean
Item
If contact successful: Type of third party contact
text
Type of third party contact
Code List
If contact successful: Type of third party contact
CL Item
Investigative site staff (4)
CL Item
Health care provider other than investigative site staff (1)
CL Item
Family member (2)
CL Item
Friend or neighbor (5)
CL Item
Other (OT)
Other type of third party contact
Item
Other type of third party contact
text
Item
Are there any new study endpoints to report?
text
new study endpoints
Code List
Are there any new study endpoints to report?
CL Item
Unknown (Third party not able to find out if subject did or did not have new study endpoint, or the only information available is vital status "death" without details) (U)
CL Item
No (Third party able to confirm no new study endpoints) (N)
CL Item
Yes (Third party able to confirm the presence of new study endpoints. Do not select this option if the only information available is vital status "death" without details) (Y)
Date endpoint information assessed by third party
Item
Date endpoint information assessed by third party
date
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial